NASDAQ
Nuo Therapeutics, Inc. (AURX) has a price/sales ratio of 28.13x as of Friday, May 22, 2026. This represents a 81.83% decrease compared to its 12-month average of 154.79x. The price-to-sales ratio evaluates a company's stock price relative to its revenue, useful for valuing companies with little or no earnings.
No price data available for this timeframe.